Data completeness
3/8 — Basic
HALOG by Bristol Myers Squibb is clinical pharmacology topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HALOG is a topical corticosteroid ointment developed by Bristol Myers Squibb that exerts anti-inflammatory, antipruritic, and vasoconstrictive effects through unclear mechanisms of action. The product is currently in pre-launch stage and carries an extensive investigational indication list spanning CNS disorders (schizophrenia, epilepsy, Alzheimer's disease, dementia, traumatic brain injury) and metabolic conditions (lysosomal storage disease, SSADH deficiency). The mismatch between topical corticosteroid pharmacology and systemic indications suggests either data quality issues or a portfolio reassignment error.
$85KPart D
Pre-LaunchMinimal commercial traction ($85K, 92 claims in 2023) suggests either niche use, data inconsistency, or early-stage patient identification; brand team likely small and focused on indication development.
Mechanism of Action
CLINICAL PHARMACOLOGY Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Study of the Role of Top-down Processes in Neuronal Reorganization and Recovery From Sensory Loss: an Exploratory Behavioral and Electroencephalographic Study in Cochlear-supported Deaf Patients
Started Mar 2026
90 enrolled
Deafness, Bilateral
A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)
Started Nov 2025
80 enrolled
Depressive Disorder, Major
Development of Electroencephalography (EEG) and Magnetoencephalography (MEG) Source Reconstruction With Fast Multipole Method
Started Jan 2025
30 enrolled
Healthy
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
Started Jan 2024
99 enrolled
Cannabis UseAlcohol Use, Unspecified
Safety and Performance Study of the Electroencephalographic Recording Device and Sound Emissions
Started Oct 2023
0Sleep Disorder
Worked on HALOG at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.